Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 7/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.45 |
| ▸ | PDE1A | P54750 | 4/20 | 0.45 |
| ▸ | PDE1B | Q01064 | 4/20 | 0.45 |
| ▸ | PDE1C | Q14123 | 4/20 | 0.45 |
| ▸ | PDE5A | O76074 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | PDE2A | O00408 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8937183 | 0.81 | KDM4E (0.43) | MEN1KMT2APDE1APDE1BPDE1C | |
| SCHEMBL7624092 | 0.80 | KDM4E (0.42) | MEN1KMT2APDE1APDE1BPDE1C | |
| SCHEMBL1804901 | 0.77 | KDM4E (0.41) | MEN1KMT2APDE1APDE1BPDE1C | |
| SCHEMBL4377951 | 0.75 | KDM4E (0.52) | MEN1KMT2APDE1APDE1BPDE1C | |
| SCHEMBL4623478 | 0.71 | KDM4E (0.38) | MEN1KMT2APDE1APDE1BPDE1C | |
| SCHEMBL5647 | 0.70 | ADORA2A (0.43) | MEN1KMT2APDE1APDE1BPDE1C | |
| SCHEMBL9765951 | 0.66 | ADORA2A (0.49) | MEN1KMT2ATSHRKDM4EALDH1A1 | |
| SCHEMBL4796600 | 0.66 | PDE4A (0.47) | MEN1KMT2APDE1APDE1BPDE1C | |
| SCHEMBL23797830 | 0.66 | HTT (0.42) | MEN1KMT2APDE1APDE1BPDE1C | |
| SCHEMBL3524432 | 0.66 | KDM4E (0.35) | MEN1KMT2APDE1APDE1BPDE1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3638265-A1 | REPROGRAMMING FIBROBLASTS TO RETINAL CELLS | University of North Texas Health Science Center (US) | 2020-04-22 | — | — | EP | disclosed |
| EP-3525788-A1 | TREATMENT OF SYNUCLEINOPATHIES | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE) (DE) | 2019-08-21 | — | — | EP | disclosed |
| WO-2018232258-A1 | REPROGRAMMING FIBROBLASTS TO RETINAL CELLS | UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER (US) | 2018-12-20 | — | — | WO | disclosed |
| WO-2018069312-A1 | TREATMENT OF SYNUCLEINOPATHIES | DEUTSCHES ZENTRUM FÜR NEURODEGENERATIVE ERKRANKUNGEN E. V. (DZNE) (DE) | 2018-04-19 | — | — | WO | disclosed |
| WO-2011146819-A2 | METHODS AND COMPOSITIONS FOR TREATMENT NF-κB-MEDIATED AND α7 INTEGRIN-SUPPRESSED DISEASES | DMD THERAPIES, LLC (US) | 2011-11-24 | — | — | WO | disclosed |
| EP-2370080-A1 | PDE1 AS A TARGET THERAPEUTIC IN HEART DISEASE | University of Utah Research Foundation (US) | 2011-10-05 | — | — | EP | disclosed |
| WO-2010065617-A1 | PDE1 AS A TARGET THERAPEUTIC IN HEART DISEASE | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2010-06-10 | — | — | WO | disclosed |
| WO-2010002492-A1 | METHODS OF USE OF ADENINE DERIVATIVES FOR THE TREATMENT OF DIABETES AND OTHER DISORDERS | UNIVERSITY OF CHICAGO (US) | 2010-01-07 | — | — | WO | disclosed |
| WO-2009002507-A1 | COMPOSITIONS AND METHODS FOR TREATING MEDICAL CONDITIONS | COMBINATORX, INCORPORATED (US) | 2008-12-31 | — | — | WO | disclosed |
| WO-2008157205-A2 | METHODS AND COMPOSITIONS FOR TREATING URINARY TRACT INFECTIONS USING AGENTS THAT MIMIC OR ELEVATE CYCLIC AMP | DUKE UNIVERSITY (US) | 2008-12-24 | — | — | WO | disclosed |
| WO-2007103373-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS | COMBINATORX, INCORPORATED (US) | 2007-09-13 | — | — | WO | disclosed |
| WO-2007089617-A2 | METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF MUSCULOSKELETAL DISORDERS AND SYMPTOMS ASSOCIATED THEREWITH | COMBINATORX, INCORPORATED (US) | 2007-08-09 | — | — | WO | disclosed |
| WO-2007079293-A2 | CANCER STEM CELLS AND USES THEREOF | HOSPITAL FOR SICK CHILDREN (CA) | 2007-07-12 | — | — | WO | disclosed |
| WO-2007056457-A2 | METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF MEDICAL CONDITIONS | COMBINATORX, INCORPORATED (US) | 2007-05-18 | — | — | WO | disclosed |
| EP-1583541-A2 | COMPOUNDS AND METHODS FOR INCREASING NEUROGENESIS | Neuronova AB (SE) | 2005-10-12 | — | — | EP | disclosed |
| WO-2004045592-A2 | COMPOUNDS AND METHODS FOR INCREASING NEUROGENESIS | NEURONOVA AB (SE) | 2004-06-03 | — | — | WO | disclosed |
| EP-1305328-A2 | MATERIALS AND METHODS FOR BINDING NUCLEIC ACIDS TO SURFACES | Lyles, Mark B. (US) | 2003-05-02 | — | — | EP | disclosed |
| WO-2002008237-A2 | MATERIALS AND METHODS FOR BINDING NUCLEIC ACIDS TO SURFACES | LYLES MARK B (US) | 2002-01-31 | — | — | WO | disclosed |
| WO-2001068137-A2 | COMPOSITIONS FOR REGULATING MEMORY CONSOLIDATION | BROWN UNIVERSITY RESEARCH FOUNDATION (US) | 2001-09-20 | — | — | WO | disclosed |
| WO-1995009636-A1 | METHOD OF INDUCING VASORELAXATION TO TREAT PULMONARY HYPERTENSION | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OFNEW YORK (US) | 1995-04-13 | — | — | WO | disclosed |